Abstract Thioredoxin is a redox protein while adiponectin is an adipokine. Their relationship has been less appreciated. Here we show that in serum of patients with acute exacerbations of chronic obstructive Pulmonary Disease, decreased activity of thioredoxin coexists with increased level of adiponectin as partial pressure of arterial oxygen decreases. From the results with adiponectin-knockout mice and in vitro experiments, we have found a reciprocal inhibitory relationship, by which adiponectin inhibits cytosolic thioredoxin (Trx1) expression, whereas serum Trx1 influences adiponectin multimerization. The association between extracellular Trx1 and adiponectin attenuates their functions. This relationship is dynamic, and correlated with a body's physiological conditions.
Introduction
Chronic obstructive pulmonary disease (COPD) is a global health problem, involving dysfunction in lungs and bronchial epithelium [1] . Acute exacerbations of COPD (AECOPD) are often associated with increased mortality. However, the efficient prevention and treatment of AECOPD are currently hampered because the detailed mechanism remains largely unclear [2] . Adiponectin is the most abundant adipokine. Recently, the close association was found between adiponectin and COPD [3] as well as AECOPDs [4] . The latter is a common presentation to emergency departments and an important cause of respiratory failure [5] . Serum adiponectin was usually excessive or inappropriate accumulation in COPD patients [6] . As such, an understanding of the mechanism that mediates or controls adiponectin effects on respiratory system is of important therapeutic values.
Human adiponectin circulates in plasma/serum as trimer (LMW), hexamer (MMW) and multimeric (HMW) isoforms [7] . Adiponectin isoforms have differential actions [8] . Mature monomeric adiponectin has a molecular weight about 26 kDa [9] . The HMW and MMW isoforms of adiponectin are composed of disulfide bonded trimer [10] . Thus, redox chemistry may provide a mechanism for regulating adiponectin actions. Indeed, a disulfide-bond A oxidoreductase-like protein (DsbA-L) was identified as a regulator of adiponectin multimerization [11] . DsbA-L contains thioredoxin folds with ''Cys-X-X-Cys'' motif [11] , and belongs to thioredoxin superfamily [12] , which is a major player in oxidative protein folding. Thioredoxin is a class of small redox proteins present in all living cells [13] . In hepatocellular carcinoma, adiponectin induced apoptosis through differential modulation of thioredoxin proteins [14] . Although Trx1 expression in lung homogenates from COPD patients did not show significant alteration [15] , changes of Trx1 in serum and respiratory system of AECOPD patients have not been well characterized.
Presently there are three distinct human thioredoxin proteins: cytosolic thioredoxin (Trx1), mitochondrial Trx (Trx2) and testis specific thioredoxin. The most well-studied is Trx1. In response to inflammation, Trx1 may be secreted into blood circulation [16] , where it coexists with adiponectin. In particular, oxidative stress plays important roles in AECOPD [17] . Trx1 and its reductase (TrxR), together with NADPH, form Trx1 system that is important in maintaining cellular redox balance and cell survival [18] . In addition, inflammation is a core feature of AECOPD [19] . Extracellular Trx1 acted as chemoattractant to attract inflammatory cells to the sites of inflammation and mediate release of some inflammatory cytokines [20] . Trx1 induction might ameliorate cigarette smoking-induced lung inflammation and emphysema in mice [21] . These observations led us to speculate a Trx1-based mechanism for adiponectin-related effects on respiratory system. In this study, AECOPD patients were grouped according to partial pressure of arterial oxygen (PaO 2 ), because the prevalence of hypoxemia is common in AECOPD patients, but not in COPD patients [22] . This uncovered the inverse correlation between adiponectin and Trx1 in serum of AECOPD patients. Using adiponectin-knockout mice' sera/ lung tissue, human bronchial epithelial cells and purified adiponectin/Trx1 as models, we further analyzed the molecular basis that underlies the interaction between adiponectin and Trx1, and found a reciprocal inhibitory relationship between them.
Materials and methods

Materials
Mammalian TrxR and recombinant human Trx1 (hTrx1) were prepared as described previously [23, 24] . hTrx1, adiponectin receptor-1 and IL-8 monoclonal antibodies were purchased from Santa Crus Biotechnology, Inc. (CA, USA). Adiponectin monoclonal antibody was from R&D Systems Inc. (MN, USA). Adiponectin ELISA kit was bought from Shanghai BlueGene Biotech Co., Ltd., China. SYBR Ò Green Real-Time PCR Master Mix was purchased from Toyobo Co., Ltd. (Osaka, Japan). Protein A?G agarose and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) monoclonal antibody were from Beyotime (Shanghai, China). Dylight 488 amine-reactive dye was from PIERCE (USA). Ni Sepharose 6 Fast Flow was from GE Healthcare Life Sciences (USA). A human bronchial epithelial cell line (16-HBE) was provided by Central South University Xiangya Medical Center. All other reagents were purchased from Sigma unless otherwise stated.
Human male serum samples were from the subjects who were treated at the First Hospital of Shanxi Medical University. COPD was defined according to GOLD criteria [25] . To define AECOPD, the following definition was used: deterioration in the respiratory status of a patient with COPD defined clinically by symptoms or signs or biochemically by arterial blood gas analysis. The Institutional Review Board of the Shanxi Medical University approved this study (No. 2011061). All procedures performed in studies were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
The male adiponectin-knockout mice (C57BL/6, n = 4) and normal mice (C57BL/6, n = 3) were used at 12 weeks of age. Adiponectin-knockout mice were kindly offered by Dr. Lianfeng Zhang, Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. C57BL/6 (B6) mice were purchased from Beijing University Experimental Animal Center (Beijing, China). All animal experiments were approved by the Animal Care and Use Committee of Beijing, China. All applicable institutional and/or national guidelines for the care and use of animals were followed.
Cell protein extraction
16-HBE cells were cultured in Dulbecco's modified eagle medium (DMEM, Invitrogen, USA) supplemented with 10 % fetal bovine serum (FBS, SiJiQing China) at 37°C in an incubator containing 5 % CO 2 . Cells were routinely split at a ratio of 1:4. To examine the effect of adiponectin on Trx1, the cell medium was replaced with DMEM without FBS when the cells grew to about 70 % confluence. After another 24 h, the medium was replaced by fresh DMEM plus adiponectin. For harvesting, the cells were washed three times with PBS and scraped with a cell scraper, followed by centrifugation to collect the cells. The latter were resuspended in 50 mmol/L potassium phosphate, 1 mmol/L EDTA, pH 7.5 (PE) buffer containing 1 mmol/L PMSF, and lysed by ultrasonication. Nuclear and cytoplasmic proteins were extracted using commercialized kit (Beyotime, China). Protein concentration in the samples was determined by the BCA method using BSA as a standard. The protein extraction was frozen at -80°C until use.
Determination of hTrx1 mRNA and Trx activity
Procedure of hTrx1 mRNA detection was as described previously [26] . Trx activity in serum/lung tissue/cell extracts was determined according to the method described previously, and expressed as an increase in absorbance at 412 nm per min per mg of Trx1, which is proportional to Trx-dependent reduction of DTNB into TNB [27] . Activity of purified hTrx1 was measured by insulin reduction assay [28] . As an intermolecular disulfide between hTrx1 and Cys73 readily forms during storage [26] , the stored hTrx1 was incubated with 100 mmol/L DTT at room temperature for 20 min, followed by dialysis against PE buffer at 4°C for 24 h, which reduces hTrx1 dimer into monomer. Then, the resulting hTrx1 was incubated with or without adiponectin (molar ratio, 1:3) for 16 h at 37°C. The activity was defined as lmol NADPH consumed per min per mg of hTrx1 using a molar extinction coefficient of 6,200 m -1 cm -1 for NADPH.
Western blotting and band quantification
Proteins (40 lg per lane unless otherwise stated) were resolved by SDS-PAGE using a 10 % or 4 %-16 % gradient gel. Other procedures were the same as previously described [29] . Antibodies were diluted with 19 TBS, 0.1 % Tween-20 (TBS-T) containing 5 % non-fat dry milk (1:500 dilution of adiponectin or hTrx1 antibody; 1:1,000 dilution of GAPDH antibody; 1:500 dilution of IL-8 antibody).
To determine the relative concentration of HWM, MHM or LWM species, the serum samples were separated by SDS-PAGE, followed by Western blotting using anti-human adiponectin monoclonal antibody. The resulting protein bands were scanned and quantified using ImageJ 1.43u. The total circulating amount of adiponectin in each sample was assumed to be 100 %. Then the density value of individual species was compared with total amount of adiponectin.
Co-immunoprecipitation (Co-IP)
Serum samples were diluted to a final protein concentration of 10 lg/lL. Other procedures were the same as described previously [29] .
Analysis of adiponectin binding to receptors
Cells (*1.2 9 10 6 per well in a 6-well plate) were detached with 0.25 % trypsin/0.2 % EDTA, collected and washed three times with ice-cold PBS. The cells were resuspended in PE buffer. The resulting cell suspension was incubated with 5 lg Dylight 488-labeled adiponectin or 5 lg Dylight 488-labeled adiponectin mixed with hTrx1 for 30 min at room temperature, followed by washing with PBS three times. Adiponectin binding to the cell surface was analyzed by flow cytometry using BD FACSCalibur flow cytometr with CellQuest software.
Statistical analysis
Comparisons of group mean values were made by independent-sample Student's t test for 2 groups and One-way ANOVA for [2 groups. P values less than 0.05 are reported as statistically significant. Analyses were performed using SPSS 18.0 software.
Results
Adiponectin as a new inhibitor of Trx1
The male subjects were grouped based on PaO 2 : normal control (n = 11), AECOPD with PaO 2 [ 80 mmHg (millimeters of mercury) (n = 8), AECOPD with PaO 2 80 to [60 mmHg (n = 16) and AECOPD with PaO 2 60 to [40 mmHg (n = 14). Through analyzing these serum samples, we found that the levels of serum adiponectin in AECOPD patients were generally higher than that in normal control. Specifically, a further increase in adiponectin level occurred as PaO 2 decreased in AECOPD patients (the upper panel of Fig. 1a) . There was significant difference in serum adiponectin level between patients with PaO 2 [ 80 mmHg and patients with PaO 2 \ 60 mmHg. Moreover, the activity of serum Trx had no significant changes in AECOPD patients with PaO 2 [ 80 mmHg relative to normal controls, but obviously decreased as PaO 2 decreased in AECOPD patients (the lower panel of Fig. 1a ). These reveal a previously unrecognized inverse correlation between serum Trx activity and adiponectin levels in AECOPD patients.
Next we tested whether adiponectin plays a role in Trx1 synthesis. Adiponectin-knockout mice showed a significant increase in the activity of serum or lung Trx (Fig. 1b) . Similarly, the protein level of serum Trx1 was enhanced significantly in adiponectin-knockout mice as compared with normal mice (Fig. 1d) . For the lung tissue, the increased activity of Trx was consistent with the enhanced levels of Trx1 protein and mRNA expression (Fig. 1c, e) . These data suggest adiponectin as a negative regulator for Trx1.
hTrx1-adiponectin complex
To investigate the association of hTrx1 with adiponectin in human serum, Co-IP experiments were conducted. As shown in Fig. 2a, hTrx1 was detected in adiponectin immunoprecipitates and adiponectin was also detected in hTrx1 immunoprecipitate. These results indicate the presence of interaction between adiponectin and hTrx1 in human serum.
Mature monomeric adiponectin has a molecular weight of *26 kDa [9] . As human adiponectin circulates in plasma/ serum mainly as trimers (LMW, *78 kDa), hexamers (MMW, *156 kDa) and 12-18-mers (HMW, [300 kDa) isoforms [7] , hTrx1 binding to different adiponectin isoforms was thus analyzed. First, purified human adiponectin (the left panel of Fig. 2b ) was used for spontaneous assembly of oligomers [30] . After stored at -20°C for month, adiponectin could associate into dimer and trimers (lane 1, the right panel of Fig. 2b ), which assembled into MMW and HMW species upon incubation at 37°C for 16 h (lane 2, the right panel of Fig. 2b ). To test whether adiponectin, prepared by ourselves, is functional, human bronchial epithelial cells were incubated with the adiponectin, by which the level of released IL-8 was significantly increased (Fig. 2c) .
Adiponectin-induced increase of IL-8 release is an ideal marker for evaluating adiponectin action because adiponectin has been known to have an ability to facilitate lung epithelia cells to release IL-8 [31] .
Then, hTrx1 was mixed with adiponectin for Western blotting analysis. Using anti-hTrx1 monoclonal antibody, a series of positive bands were observed ranging from 12 to *170 kDa only in the presence of adiponectin (the left panel of Fig. 2d ). This result indicates that hTrx1 may bind to the isoforms of adiponectin except HMW isoforms that have molecular weight of [300 kDa. The binding still occurred when Cys-to-Ser mutants of hTrx1 or IAMmodified hTrx1 were used instead of native hTrx1 (the left panel of Fig. 2b) . In IAM-modified hTrx1, all five Cys residues (including Cys32 and Cys35) were alkylated with IAM. These results preclude the involvement of hTrx1-Cys residues in binding to adiponectin leading to the formation of stable hTrx1-adiponectin complexes. The high-molecular-weight positive bands were converted into the bands corresponding to hTrx1 monomer/dimer after heating for [44] . be Changes of Trx activity (b), Trx1 mRNA expression (c) and protein level (d, e) in adiponectin-knockout mice. In d-e, Upper panels, Western blots in which GADPH was used as loading control. Lower panels, the protein bands in the Western blots were scanned and quantified using ImageJ software. Control group (n = 3) and adiponectin-knockout group (n = 4). All data represented by the histogram are mean ± SD; *P \ 0.05; **P \ 0.01 10 min at 95°C (the right panel of Fig. 2d ). These results are related to the non-covalent binding between hTrx1 and adiponectin.
We then analyzed whether hTrx1 binding to adiponectin attenuates their biological activities. As shown in Fig. 2e , the activity of hTrx1 in hTrx1-adiponectin mixture was apparently lower than that in hTrx1 solution free from adiponectin.
Inverse correlation between serum Trx1 activity and HMW adiponectin levels
Adiponectin isoforms vary in biological potency [8] . HMW and MMW isoforms of adiponectin are composed of disulfide bonded trimer [10] . To explore the effect of Trx activity on adiponectin isoform distribution, the serum samples were divided based on Trx activity. Elevating serum Trx activity seemed to mainly correlate with decreased HMW species and increased LMW species (Fig. 3a, b) . To confirm this observation, we performed a series of experiments. Addition of hTrx1 system into human serum samples led to converse larger oligomers into smaller species of adiponectin (Fig. 3c) . The results with Cys-to-Ser mutants of hTrx1 showed that such a conversion could not take place once mutation of Cys32/Cys35 to Ser was introduced into hTrx1 (Fig. 3d) . The Cys32/Cys35 couple in hTrx1 just fits well with electron transfer function. Moreover, none of NADPH, TrxR or hTrx1 can be omitted (Fig. 3e) . Therefore, the electron transfer pathway is proposed as NADPH ? TrxR ? hTrx1 ? HMW adiponectin isoforms. Human serum/plasma is known to . c Effect of adiponectin oligomers on IL-8 production by 16-HBE cells. The cells were exposed to 20 lg adiponectin oligomers for 24 h, then the medium was concentrated using ultrafiltration membrane with cutoff of 3 kDa. IL-8 level in the medium was analyzed by Western blotting following 15 % SDS-PAGE. d Western blots. Association of hTrx1 with adiponectin oligomers. Wild-type hTrx1, Cys-to-Ser mutants of hTrx1 or IAM-modified hTrx1 were, respectively, incubated with adiponectin oligomers (molar ratio, 1:3) at 37°C for 16 h, which were then divided into two parts. One of them was heated at 95°C for 10 min (the right panel) and the other was not (the left panel), which were then separated on non-reducing SDS-PAGE. e hTrx1 activity after incubation with or without adiponectin oligomers (molar ratio, 1:3) at 37°C for 16 h. Adipo, adiponectin; **P \ 0.01 contain Trx1, TrxR1 and NADPH [16, 32, 33] . Our results present evidence showing association of serum Trx1 activity with adiponectin isoform distribution 3.4 hTrx1 suppressed the effect of adiponectin on human bronchial epithelial cells
Concerning the interaction between serum hTrx1 and adiponectin, the effect of hTrx1 on adiponectin binding to its receptors was tested using human bronchial epithelial cells. After the cells were treated with adiponectin or adiponectin-hTrx1 mixture for 30 min, respectively, it was obvious that the presence of hTrx1 could reduce adiponectin binding to its receptors by 50 % (Fig. 4a) , and could significantly attenuate adiponectin-induced decrease in cellular Trx activity, hTrx1 mRNA expression and hTrx1 protein level (Fig. 4b-d ).
Discussion
In this study, the observation of an inverse correlation between serum Trx activity and adiponectin level in AECOPD patients led to the finding that there is a reciprocal inhibitory relationship between adiponectin and hTrx1. Within this context, adiponectin inhibits hTrx1 synthesis and activity, while hTrx1 influences HMW adiponectin level and adiponectin binding to receptors. A previous report by Lehtonen et al. [15] also showed the correlation between Trx and COPD. Similar to their results that failed to detect the decreased Trx1 in lung tissue from COPD patients, AECOPD patients with PaO 2 [ 80 mmHg did not show decreased activity of serum Trx (Fig. 1a) . However, the prevalence of hypoxemia is common in AECOPD patients, but not in COPD patients [22] . Following a decrease in PaO 2 , the correlation between increased serum adiponectin and decreased Trx activity appeared in AECOPD patients. Possible mechanisms underlying low PaO 2 -induced increase in serum adiponectin level are probably through inactivation of transcription factor CREB, a negative regulator of adiponectin gene expression [34] , and enhancing transcription factor PPARc activity, a positive regulator of adiponectin gene expression [35] . Trx1 is essential for the activities of CREB and transcription factor FoxO1 [36, 37] that may suppress PPARc gene expression [38] . However, accumulated 4-hydroxynonenal (4-HNE) under hypoxia conditions [39] is a potent inhibitor of Trx1 [40] (outline in Fig. 4e ). This proposed mechanism is consistent either with 4-HNEinduced elevation in adiponectin gene expression [41] , or with our observation that the level of serum 4-HNE in AECOPD patients with PaO 2 \ 80 mmHg was remarkably increased (manuscript in preparation). This mechanism also fits with the fact that adiponectin level was increased almost fourfold in the patients with PaO 2 [ 80 mmHg as compared with control, but no difference in Trx activity was observed between the same two groups. On the other hand, adiponectin-knockout mice are particularly informative to demonstrate adiponectin as a new inhibitor of Trx1. These results can be extended to human serum/plasma and cells. Adiponectin at molar concentration of threefold over hTrx1 causes a decrease in Trx activity (Fig. 2e) . In healthy human plasma/serum, the level of adiponectin is about 0.5-30 lg/mL (19.2-1,154 lmol/L) [42] , and the level of serum hTrx1 is about 24.77 ± 2.16 ng/mL (*2 lmol/L) [27] . By the interaction between adiponectin and hTrx1 (Fig. 2a) , direct suppression of Trx activity by adiponectin in human serum/plasma most likely occurs. Moreover, 30 lg/mL adiponectin present in cell culture media yielded a significantly inhibitory effect on cellular Trx1. Under AECOPD conditions, serum adiponectin to hTrx1 molar ratio is further increased, suppression of Trx1 by adiponectin would become more dominant. However, patients with other diseases, such as type 2 diabetes, have a significant increase in level of serum Trx1 [43] , accompanied by a significant decrease in level of plasma/serum adiponectin [44] . In such cases, interaction of adiponectin with hTrx1 may do a favor for hTrx1 to interfere with adiponectin binding to its receptors (Fig. 4a) . This is in keeping with the observation that adiponectin-bound with hTrx1 exhibited little inhibitory effect on cellular Trx1 (Fig. 4b-d) . In addition, an elevated level of serum Trx1 in patients with type 2 diabetes certainly appears more attractive, as it may associate with the fact that HMW isoforms of adiponectin are selectively downregulated in type 2 diabetes [45] . Two properties mark out serum Trx1 as candidate for regulating serum adiponectin: (1) Trx1 may use Cys32/Cys35 couple for transferring electrons from NADPH via TrxR to HMW adiponectin; (2) Trx1-adiponectin complex is identified in human serum.
Following this reasoning, we would predict that body health status associates with the balance between Trx1 and adiponectin. An impaired balance between them seems to be one of the potential mechanisms involved in certain disease progression, such as AECOPD and type 2 diabetes.
